neobookRx
GuidelinesOther guideline

ABCDE Assessment of an Elevated Viral Load

ABCDE Assessment  Mental Health Disorders   Remember, an elevated VL in a pregnant or breastfeeding mother is a MEDICAL EMERGENCY! Every week she continues with an elevated VL increases her risk for vertical transmission!   A thorough assessment is essential for any client with a viral load measuring ≥ 50 c/mL Adherence Is adherence to medication poor? Ask about factors that may in

ABCDE Assessment 

Mental Health Disorders


 Remember, an elevated VL in a pregnant or breastfeeding mother is a MEDICAL EMERGENCY! Every week she continues with an elevated VL increases her risk for vertical transmission!


 

A thorough assessment is essential for any client with a viral load measuring ≥ 50 c/mL
Click on the image to enlarge
Adherence
Is adherence to medication poor?
Ask about factors that may influence adherence e.g.
- Medication side-effects,
- Mental health disorders (see mental health screen below),
- Alcohol or substance abuse,
- Poor social support or
- Non-disclosure.

Pregnant women may experience nausea, heartburn, and constipation. Assess the need for symptomatic treatment with an anti-emetic, anti-diarrhea agent, or fibre supplement.
Tips
Ask open ended questions e.g.
“What makes it difficult for you to take your treatment?”, and
“How many doses have you missed this week?”

Be non-judgemental. Statements like “we all miss a dose now and then” can encourage a client to be more open.
Click on the image to enlarge
Bugs (Infections)
Check for symptoms and signs of infection.
Do a TB and STI screen.
Remember that immune compromised and pregnant clients may not exhibit overt symptoms of TB. If in doubt, do a TB GXP.
Click on the image to enlarge
Correct Dose
Is the client on the correct dose for her weight? This is especially applicable to young or malnourished girls who may have recently gained weight, or clients with previous renal impairment.
Click on the image to enlarge
Drug Interactions
Are there any potential drug interactions? Consider:
- Other prescribed treatment e.g. rifampicin, anti-epilepsy drugs
- Over the counter treatment e.g. antacids
- Supplements and herbal/traditional medications e.g. St John’s wort
If in any doubt, call the

HIV Hotline
0800 212 506
Click on the image to enlarge
RE-sistance
Consider HIV drug resistance if other causes of virological failure have been excluded and the client is adherent to their medication. Refer to the algorithm for
“Management of confirmed virological failure” in the 2023 ART Clinical Guideline

MENTAL HEALTH DISORDERS

Pregnancy, childbirth and the first year after birth are often stressful times for women. Mental health conditions affect a person’s feelings, thoughts, behaviours, and functioning. Women with mental disorders may struggle to use health and social services that are available and may struggle to bond with and parent their children.

Mental Health Screen

When to screen Screen at booking visit in antenatal care, once during each trimester, and once during the postnatal period (from 6 weeks to 3 months). Thereafter, screen at regular intervals for up to one year.
How to screen Ask the following 3 screening questions, using a gentle and kind attitude:
In the last 2 weeks, have you felt unable to stop worrying or thinking too much? (Yes = 1 point; No = 0)
In the last 2 weeks, have you felt down, depressed, or hopeless? (Yes = 1 point; No = 0)
In the last 2 weeks, have you had thoughts and plans to harm yourself or commit suicide? (Yes = 1 point; No = 0)
When to refer If the Total score across the 3 questions = 2 or 3 points, refer
If a patient answers ‘yes’ to the self-harm question, refer urgently for a mental health assessment with a medical officer or mental health professional
Additional Resources: Maternity Care Guidelines; Primary Healthcare and Adult Hospital Standard Treatment Guidelines (STGs);
Adult Primary Care (APC); FAMSA 0119757106/7; Lifeline 0861 322 322

Click here for the pdf.


South African National Department of Health, Guideline for Vertical Transmission Prevention of Communicable Infections, Version 2_August 2023

Drugs mentioned

NeoHealth® ID 37194 · updated 11/26/2024